Literature DB >> 31773391

Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study.

Ismihan Sunar1, Sebnem Ataman2, Kemal Nas3, Erkan Kilic4, Betul Sargin5, Sevtap Acer Kasman6, Hakan Alkan7, Nilay Sahin8, Gizem Cengiz9,10, Nihan Cuzdan11, Ilknur Albayrak Gezer12, Dilek Keskin13, Cevriye Mülkoğlu14, Hatice Resorlu15, Ajda Bal16, Mehmet Tuncay Duruöz6, Okan Küçükakkaş17, Ozan Volkan Yurdakul17, Meltem Alkan Melikoglu18, Yıldıray Aydın3, F Figen Ayhan14,19, Hatice Bodur20, Mustafa Calis9, Erhan Capkın21, Gul Devrimsel22, Kevser Gok23, Sami Hizmetli24, Ayhan Kamanlı3, Yaşar Keskin17, Hilal Kocabas25, Oznur Kutluk26, Nesrin Şen27, Omer Faruk Şendur28, Ibrahim Tekeoğlu3, Sena Tolu29, Murat Toprak30, Tiraje Tuncer26.   

Abstract

Psoriatic arthritis (PsA) is an inflammatory arthritis with distinct phenotypic subtypes. Enthesitis is assigned as a hallmark of the disease, given its significant relations to disease activity and quality of life. Our objective is to evaluate the prevalence of enthesitis and its association with some clinical parameters, particularly quality of life, using data from a national registry. Patients with PsA meeting ClASsification criteria for Psoriatic Arthritis (CASPAR) were enrolled by means of a multi-centre Turkish League Against Rheumatism (TLAR) Network Project. The following information was recorded in web-based case report forms: demographic, clinical and radiographic data; physical examination findings, including tender and swollen joint counts (TJC and SJC); nail and skin involvement; Disease Activity Score-28 for Rheumatoid Arthritis with Erythrocyte Sedimentation Rate (DAS 28-ESR); Bath Ankylosing Spondylitis Disease Activity Index (BASDAI); Maastricht Ankylosing Spondylitis Enthesitis Score (MASES); Psoriasis Area Severity Index (PASI); Bath Ankylosing Spondylitis Radiology Index for the spine (BASRI-s); Health Assessment Questionnaire (HAQ); Bath Ankylosing Spondylitis Functional Index (BASFI); Health Assessment Questionnaire for the spondyloarthropathies (HAQ-s); Psoriatic arthritis quality of Life scale (PsAQoL); Short Form 36 (SF-36); Hospital Anxiety Depression Scale (HADS); Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F); and Fibromyalgia Rapid Screening Tool (FiRST) scores. The patients were divided into two groups, namely with and without enthesitis, based on the triple Likert-type physician-reported statement of 'active enthesitis', 'history of enthesitis' or 'none' in the case report forms. Patients with active enthesitis were compared to others in terms of these clinical parameters. A total of 1130 patients were enrolled in this observational study. Of these patients, 251 (22.2%) had active enthesitis according to the clinical assessment. TJC, HAQ-s, BASDAI, FiRST and PsAQoL were significantly higher whereas the SF-36 scores were lower in patients with enthesitis (p < 0.05). Chronic back pain, dactylitis, and tenosynovitis were more frequent in the enthesopathy group (59.4%/39%, 13.1%/6.5% and 24.7%/3.4%, respectively). Significant positive correlations between the MASES score and the TJC, HAQ, DAS 28-ESR, BASDAI, FiRST and PsAQoL scores, and a negative correlation with the SF-36 score were found. When linear regression analysis was performed, the SF-36 MCS and PCS scores decreased by - 9.740 and - 11.795 units, and the FiRST scores increased by 1.223 units in patients with enthesitis. Enthesitis is an important involvement of PsA with significant relations to quality of life determined with PsAQoL and SF-36 scores. Our study found higher frequency of dactylitis and chronic back pain, and worse quality of life determined with SF-36 and PsAQoL scores in patients with enthesitis.

Entities:  

Keywords:  Disease activity; Enthesitis; Enthesopathy; Psoriatic arthritis; Quality of life; Registry

Year:  2019        PMID: 31773391     DOI: 10.1007/s00296-019-04480-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  52 in total

1.  The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.

Authors:  Devy Zisman; Dafna D Gladman; Matthew L Stoll; Vibeke Strand; Idit Lavi; Joyce J Hsu; Elizabeth D Mellins
Journal:  J Rheumatol       Date:  2017-02-01       Impact factor: 4.666

2.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study.

Authors:  William Taylor; Dafna Gladman; Philip Helliwell; Antonio Marchesoni; Philip Mease; Herman Mielants
Journal:  Arthritis Rheum       Date:  2006-08

Review 3.  Psoriatic Arthritis.

Authors:  Christopher T Ritchlin; Robert A Colbert; Dafna D Gladman
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

4.  Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST).

Authors:  Serge Perrot; Didier Bouhassira; Jacques Fermanian
Journal:  Pain       Date:  2010-05-21       Impact factor: 6.961

5.  The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods.

Authors:  E Lubrano; A Marchesoni; I Olivieri; S D'Angelo; A Spadaro; W J Parsons; A Cauli; C Salvarani; A Mathieu; E Zaccara; N Ferrara; P S Helliwell
Journal:  Clin Exp Rheumatol       Date:  2009 Nov-Dec       Impact factor: 4.473

Review 6.  Fibromyalgia: the prototypical central sensitivity syndrome.

Authors:  Chad S Boomershine
Journal:  Curr Rheumatol Rev       Date:  2015

7.  Ultrasound entheseal abnormalities at the distal interphalangeal joints and clinical nail involvement in patients with psoriasis and psoriatic arthritis, supporting the nail-enthesitis theory.

Authors:  Maria Laura Acosta-Felquer; Santiago Ruta; Javier Rosa; Josefina Marin; Leandro Ferreyra-Garrot; Maria Laura Galimberti; Ricardo Galimberti; Ricardo Garcia-Monaco; Enrique R Soriano
Journal:  Semin Arthritis Rheum       Date:  2017-05-11       Impact factor: 5.532

8.  Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging.

Authors:  I Olivieri; L Barozzi; L Favaro; A Pierro; M de Matteis; C Borghi; A Padula; S Ferri; P Pavlica
Journal:  Arthritis Rheum       Date:  1996-09

9.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Authors:  S Garrett; T Jenkinson; L G Kennedy; H Whitelock; P Gaisford; A Calin
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Assessment of enthesitis in ankylosing spondylitis.

Authors:  L Heuft-Dorenbosch; A Spoorenberg; A van Tubergen; R Landewé; H van ver Tempel; H Mielants; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

View more
  8 in total

1.  Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial.

Authors:  Frank Behrens; Philipp Sewerin; Eugenio de Miguel; Yusuf Patel; Anastas Batalov; Eva Dokoupilova; Christine Kleinmond; Effie Pournara; Ankita Shekhawat; Claudia Jentzsch; Annette Wiedon; Xenofon Baraliakos
Journal:  Rheumatology (Oxford)       Date:  2022-07-06       Impact factor: 7.046

2.  Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?

Authors:  Giovanni Adami; Elisabetta Gerratana; Fabiola Atzeni; Camilla Benini; Elisabetta Vantaggiato; Denise Rotta; Luca Idolazzi; Maurizio Rossini; Davide Gatti; Angelo Fassio
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-02-15       Impact factor: 5.346

Review 3.  New Perspectives on Diagnosing Psoriatic Arthritis by Imaging Techniques.

Authors:  Mihaela Ionela Sarbu; Radu Baz; Dragos Negru; Nicolae Sarbu; Doriana Cristea Ene; Daniela Corche; Aurel Nechita; Silvia Fotea; Lucretia Anghel; Alin Laurentiu Tatu
Journal:  Open Access Rheumatol       Date:  2021-12-22

4.  Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis.

Authors:  George Gondo; Edward Hadeler; Nicholas Brownstone; Emanual Maverakis; Joseph F Merola; April W Armstrong; Tina Bhutani; Stacie J Bell; Wilson Liao
Journal:  Dermatol Ther (Heidelb)       Date:  2022-03-07

5.  Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial.

Authors:  Philip S Helliwell; Phillip J Mease; Arthur Kavanaugh; Laura C Coates; Alexis Ogdie; Atul Deodhar; Vibeke Strand; Gregory Kricorian; Lyrica X H Liu; David Collier; Dafna D Gladman
Journal:  RMD Open       Date:  2022-07

Review 6.  A clinical practice guideline for the screening and assessment of enthesitis in patients with spondyloarthritis.

Authors:  Xinyu Wu; Dong Liu; Yanfei Li; Ya Xie; Liudan Tu; Yanli Zhang; Xi Zhang; Linkai Fang; Xiqing Luo; Zhiming Lin; Zetao Liao; Limin Rong; Jie Ren; Yuqi Zhou; Niansheng Yang; Jian Xu; Hua Zhang; Baijie Xu; Zhenbiao Wu; Feng Zhan; Zhenbin Li; Weiguo Xiao; Shengyun Liu; Yi Zhou; Shanhui Ye; Qing Lv; Lijun Zhang; Dongbao Zhao; Shanzhi He; Like Zhao; Lijun Wu; He Lin; Yunxiao Zhu; Donggeng Guo; Zehong Yang; Budian Liu; Kehu Yang; Jieruo Gu
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

7.  Analysis of musculoskeletal side effects of oral Isotretinoin treatment: a cross-sectional study.

Authors:  Nermin Karaosmanoğlu; Cevriye Mülkoğlu
Journal:  BMC Musculoskelet Disord       Date:  2020-09-25       Impact factor: 2.362

8.  Factors Associated with Health-Related Quality of Life in Psoriatic Arthritis Patients: A Longitudinal Analysis.

Authors:  Lydia Abasolo; Luis Rodriguez-Rodriguez; Dalifer Freites Nuñez; Alfredo Madrid-García; Leticia Leon; Gloria Candelas; Mercedes Núñez; Natalia Bello; Silvia Díaz; Benjamín Fernández-Gutiérrez
Journal:  Rheumatol Ther       Date:  2021-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.